The AI-pharma gold rush of 2021–2022 was loud, dazzling, and, like many phenomena in tech, perhaps preceded its maturity. Billions of dollars in bets were placed on the promise that artificial ...

To further harness global opportunity in pharma and life sciences, Indian industry needs to move up on the value chain to become a capability leader with focus on high-value products, according to ...

(R to L) EY's Ricardo Vilanova, Lila Bioscience's Molly Gibson, Merck's Iya Khalil, Insitro's Mary Rozenman, and Gallop Oncology's Luba Greenwood at BIO 2025. When Google shook the foundations of the ...

Earnings call Chesapeake Utilities achieved 12% adjusted EPS growth and 16% adjusted net income growth in 2025, marking its 19th straight year of earnings gains. Management reaffirmed its 2028 EPS ...

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. If you are wondering whether Organon’s current share price reflects its true ...

Our strategy is built around disciplined focus and platform leverage. We are concentrating our technology and business development efforts on highly valuable pharmaceutical and nutraceutical markets.” ...

Though Freund's complete adjuvant effectively increases immune response to vaccines in various species, its potentially severe inflammatory effects have led many animal researchers to seek alternative ...